Your Zepbound out of pocket cost comes down to one question. Does a commercial insurance plan cover the drug, or are you paying cash? The same 28-day box costs one person $25 and the next person $1,086.37, and nothing about the medicine changes, only the payment path. This page maps every 2026 path, from the $25 savings card to compounded tirzepatide under $150 a month, so you know exactly which price is yours.
Quick Answer: Zepbound Out of Pocket Cost in 2026
With commercial insurance that covers Zepbound, the savings card drops your cost to $25 a month. Without coverage, LillyDirect vials run $299 to $449, TrumpRx charges about $350, and compounded tirzepatide through licensed telehealth providers like Yucca Health starts around $146 a month. Full list price is $1,086.37.
🔑 Key Takeaways
- The Zepbound list price is $1,086.37 per 28-day supply at every dose strength, but almost nobody has to pay it once they know the programs below.[1]
- Commercial insurance plus the Lilly savings card cuts the price to $25 per fill, with a $1,300 annual benefit cap. If your plan refuses coverage, the card still unlocks $499 pens.[1]
- LillyDirect self-pay vials dropped to $299 to $449 a month in December 2025 and can now be picked up at about 4,600 Walmart pharmacies.[2]
- Two government-linked routes arrived in 2026: TrumpRx at about $350 a month and the Medicare GLP-1 Bridge at a $50 copay starting July 1, 2026.[3][4]
- The lowest monthly number of all belongs to compounded tirzepatide, the same active ingredient, prescribed by licensed providers and dispensed by state-licensed pharmacies for $146 to $258 through Yucca Health.
Telehealth Comparison Table
Before the full price breakdown: if brand-name pricing is out of reach, these are the two licensed telehealth providers our readers use most for lower-cost compounded tirzepatide.
Zepbound Out of Pocket Cost in 2026: Every Payment Path
Seven realistic prices exist right now. Only one of them is yours, and the table below tells you which. Figures are per month for a 28-day supply.
The rest of this guide walks each row in order of how many people it applies to, starting with the number on the pharmacy receipt. For the deeper coupon mechanics behind the savings card, our Zepbound cost guide and savings card breakdown cover every fine-print rule.
Without Insurance, the Sticker Price Is $1,086.37. Never Pay It
Every dose costs the same. Eli Lilly prices Zepbound at $1,086.37 per 28-day supply whether you inject 2.5 mg or 15 mg, because the price is set per box of four pens, not per milligram.[1] At a retail counter, pharmacy markup often pushes the cash total to $1,100 to $1,300 before any discount.
Discount cards barely help here. GoodRx and similar coupons hover near $995 on brand Zepbound because manufacturer contracts leave third parties almost no room to discount it. The real levers for cash buyers are Lilly's own channels and compounded tirzepatide, both covered below. If you are starting from zero, our guide on buying Zepbound online shows every legitimate storefront.
With Insurance: What Your Copay Actually Looks Like
Coverage is the whole game. When a commercial plan covers Zepbound, your out of pocket cost is a copay, typically $25 to $150 a month once any deductible is met. Add the free Zepbound Savings Card from Eli Lilly and that copay falls to as little as $25 per fill, up to a $1,300 annual benefit.[1]
Two catches matter:
- Government plans are excluded. Medicare, Medicare Advantage, Medicaid, TRICARE, and VA coverage cannot use the manufacturer card at all.[1]
- Formularies keep moving. CVS Caremark dropped Zepbound in July 2025 and restores it in October 2026, and Blue Cross Blue Shield of Massachusetts pulled weight-loss coverage in January 2026. Recheck your formulary every January.
If your plan covers the drug only on paper, expect a prior authorization: BMI thresholds, documented weight history, sometimes step therapy. Most denials are beatable, and appeals with proper documentation succeed more often than not. Our Zepbound prior authorization guide walks the exact criteria and appeal template. And if the plan simply excludes Zepbound, the savings card still drops single-dose pens to $499 a month, no coverage required.
LillyDirect Vials: $299 to $449 a Month Self-Pay
This is Lilly's official cash-pay route. LillyDirect sells single-dose Zepbound vials directly to self-pay patients with a valid prescription, and prices dropped on December 1, 2025:[2]
Three practical notes. You inject from a vial with a syringe instead of a prefilled pen. Reorders only work inside a set refill window, roughly 45 days, so lapses reset your access. And since November 2025 you can pick vials up at about 4,600 Walmart pharmacies instead of waiting on cold-chain shipping. The full tier-by-tier breakdown lives in our LillyDirect cost guide.
TrumpRx and the Medicare GLP-1 Bridge: The New 2026 Routes
Two new doors opened this year.
TrumpRx went live in February 2026 at trumprx.gov, selling Zepbound for about $350 a month to anyone, no insurance required, with fulfillment routed through LillyDirect.[3] It undercuts LillyDirect's maintenance tiers but not its $299 starting dose, so compare by your dose before picking a lane.
The Medicare GLP-1 Bridge starts July 1, 2026. Eligible Medicare beneficiaries pay a flat $50 monthly copay for Zepbound KwikPen, regardless of income.[4] Eligibility requires a BMI of 35 or higher, or 27 or higher with a weight-related condition, and the $50 does not count toward your Part D deductible or out-of-pocket maximum.[5] Vials are excluded, and so are patients already covered for sleep apnea treatment. For years Medicare paid nothing toward weight-loss use, so a $50 cap is the biggest access shift since Zepbound's approval criteria were written.
The Cheapest Option: Compounded Tirzepatide Through Licensed Telehealth
Now the row that wins on price. Compounded tirzepatide contains the same active ingredient as Zepbound, prescribed through a telehealth consultation with a licensed US provider and dispensed by state-licensed compounding pharmacies. No insurance, no prior authorization, no formulary fight.
Yucca Health is the cheapest option we track for this route, at $146 to $258 a month. The price includes the provider consultation and shipping, and the top of that range still lands about 40% below LillyDirect's $449 maintenance vials. Against the $1,086.37 list price, it is roughly an 80% cut. That gap is why cash payers who plan to stay on tirzepatide for a year or more increasingly start here; across 12 months the difference versus maintenance-dose LillyDirect exceeds $2,200.
Be clear-eyed about the tradeoff. Compounded tirzepatide is not the brand product and does not pass through the FDA's brand-drug review, so quality rests on the licensing and testing of the pharmacy that makes it. You also draw doses from a vial with a syringe rather than clicking a pen. Sticking to providers that use licensed US pharmacies, the way Yucca Health does, is what separates this route from the gray-market powder sellers we warn about in our compounding pharmacy guide. For a ranked list of every legitimate low-cost source, see cheapest tirzepatide in 2026.
In head-to-head trials, tirzepatide produced 20.9% average body weight loss over 72 weeks at the 15 mg dose, and that result belongs to the molecule, not the label on the box.[6]
Zepbound Out of Pocket Cost Over 12 Months
Monthly prices hide the real number. A year of treatment is where the paths separate by thousands of dollars:
*The savings card benefit caps at $1,300 per year; heavy deductibles can push your true annual total above $300.
Five Steps to Your Lowest Zepbound Price
- Check your formulary first. Log into your insurance member portal or call the pharmacy line and ask two questions: is Zepbound covered, and does it need prior authorization?
- Covered? Activate the savings card before your first fill. It is free at zepbound.lilly.com/savings, takes five minutes, and drops eligible copays to $25.[1]
- Denied? Appeal before you pay cash. Well-documented appeals succeed more often than they fail, and LillyDirect can bridge the 2 to 4 weeks while you wait.
- No coverage? Compare LillyDirect and TrumpRx by dose. $299 wins at 2.5 mg through LillyDirect; at maintenance doses TrumpRx's flat $350 beats the $449 vial tier.[2][3]
- Paying cash long term? Price the compounded route. A Yucca Health consultation takes minutes online, and at $146 to $258 a month it is the cheapest licensed path to tirzepatide sold today.
Frequently Asked Questions
References
- Eli Lilly. Zepbound Savings and Insurance Options. Zepbound.lilly.com, 2026.
- Eli Lilly. LillyDirect Self Pay Pharmacy Solutions: Zepbound. Lilly.com, 2026.
- TrumpRx. Zepbound Direct Purchase Pricing. TrumpRx.gov, 2026.
- Medicare.gov. Medicare GLP-1 Bridge: GLP-1 Drugs for $50 a Month. CMS Publication 12234, 2026.
- KFF. What Medicare's Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries. Kaiser Family Foundation, 2026.
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022.
- FDA. Zepbound (tirzepatide) Prescribing Information. AccessData.fda.gov, 2023.
- FDA. FDA Approves New Medication for Chronic Weight Management. FDA.gov, November 2023.
